Moreover, after treatment with autologous hematopoietic stem cell transplant in MS patients, Arruda et al. observed a temporary increase in the number of regulatory T cells and PD-1- expressing CD8+ T cells (90). Here, CD8A is linked to myeloid sarcoma.